Coy D Heldermon Selected Research

Coy D Heldermon Research Topics

Disease

11	Neoplasms (Cancer) 07/2022 - 11/2016
10	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2014
4	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2021 - 08/2007
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 06/2021 - 05/2010
3	Mucopolysaccharidoses 06/2021 - 08/2007
2	Febrile Neutropenia 07/2022 - 11/2021
2	Triple Negative Breast Neoplasms 01/2019 - 04/2017
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
1	Lymphoma (Lymphomas) 11/2021
1	Neutropenia 11/2021
1	Pneumococcal Pneumonia 01/2020
1	Obesity 01/2020
1	Necrosis 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Overweight 01/2018
1	Carcinoma (Carcinomatosis) 11/2016
1	Multiple Myeloma 02/2016
1	Hyponatremia 10/2014
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
4	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2022 - 04/2017
4	EnzymesIBA 06/2021 - 08/2007
3	DisulfidesIBA 01/2022 - 04/2017
3	Carbonic Anhydrase IXIBA 01/2019 - 01/2018
3	Estrogen ReceptorsIBA 01/2018 - 04/2017
3	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 09/2014 - 08/2007
2	Biosimilar PharmaceuticalsIBA 07/2022 - 11/2021
2	Acetylglucosaminidase (NAGase)IBA 01/2021 - 09/2014
2	Pharmaceutical PreparationsIBA 01/2019 - 04/2017
2	CaspasesIBA 01/2019 - 01/2019
2	Lapatinib (GW572016)FDA Link 01/2019 - 01/2016
2	Cadherins (E-Cadherin)IBA 11/2016 - 09/2014
2	Hexosaminidases (Hexosaminidase)IBA 05/2010 - 08/2007
1	pegfilgrastim (Neulasta)FDA Link 07/2022
1	Death Domain ReceptorsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2021
1	GlucuronidaseIBA 06/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	ametantrone (HAQ)IBA 01/2020
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2020
1	InterferonsIBA 01/2020
1	23-valent pneumococcal capsular polysaccharide vaccineIBA 01/2020
1	Attenuated VaccinesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2019
1	LigandsIBA 01/2019
1	Proline (L-Proline)FDA Link 01/2019
1	Protons (Proton)IBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2019
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019
1	SulfonamidesIBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2017
1	AntibodiesIBA 04/2017
1	Phosphotransferases (Kinase)IBA 04/2017
1	thymoglobulin FDA Link 02/2016
1	Hemoglobins (Hemoglobin)IBA 09/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2014
1	Maytansine (Maitansine)IBA 10/2014
1	Epithelial Cell Adhesion MoleculeIBA 09/2014
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 09/2014
1	AcetyltransferasesIBA 09/2014
1	VimentinIBA 09/2014
1	Transcription Factors (Transcription Factor)IBA 09/2014
1	heparan sulfate sulfataseIBA 09/2014
1	N-acetylglucosamine-6-sulfataseIBA 09/2014

Therapy/Procedure

4	Therapeutics 06/2021 - 04/2017
2	Drug Therapy (Chemotherapy) 07/2022 - 11/2021
1	Aftercare (After-Treatment) 01/2019
1	Hormonal Contraception 01/2018
1	Transplantation 11/2016
1	Investigational Therapies (Experimental Therapy) 09/2014